Zobrazeno 1 - 10
of 474
pro vyhledávání: '"KIR3DL2"'
Autor:
Li Y; Department of Pediatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Zeng T; Department of Infectious Diseases, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Huang P; Department of Epidemiology, School of Public Health, Center for Global Health, Nanjing Medical University, Nanjing, China., Tan W; Nanjing Bioengineering (Gene) Technology Center for Medicines, Nanjing, China., Feng Y; Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, China., Xia X; Yunnan Provincial Key Laboratory of Public Health and Biosafety, Kunming Medical University, Kunming, China., Feng Z; Department of Occupational Disease Control, Chengdu Center for Disease Control and Prevention, Chengdu, China., Shen C; Department of Immunization Program, Nanjing Municipal Center for Disease Control and Prevention, Nanjing, China., Fan H; Department of Information, First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Zhu C; Department of Infectious Diseases, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; Department of Tropical Diseases, the Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China., Yin W; Department of Infectious Diseases, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Qian L; Department of Epidemiology, School of Public Health, Center for Global Health, Nanjing Medical University, Nanjing, China., Ren C; Department of Infectious Diseases, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Yue M; Department of Infectious Diseases, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Publikováno v:
Journal of medical virology [J Med Virol] 2024 Jul; Vol. 96 (7), pp. e29776.
Identification of the novel KIR3DL2*00711 allele by sequencing-based typing in a Chinese individual.
Autor:
Chen C; HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, Zhejiang Province, China.; HLA Typing Laboratory, Key Laboratory of Blood Safety Research, Hangzhou, Zhejiang Province, China., Wang J; HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, Zhejiang Province, China.; HLA Typing Laboratory, Key Laboratory of Blood Safety Research, Hangzhou, Zhejiang Province, China., Tao S; HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, Zhejiang Province, China.; HLA Typing Laboratory, Key Laboratory of Blood Safety Research, Hangzhou, Zhejiang Province, China., He J; HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, Zhejiang Province, China.; HLA Typing Laboratory, Key Laboratory of Blood Safety Research, Hangzhou, Zhejiang Province, China., Zhu F; HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, Zhejiang Province, China.; HLA Typing Laboratory, Key Laboratory of Blood Safety Research, Hangzhou, Zhejiang Province, China.
Publikováno v:
HLA [HLA] 2021 Oct; Vol. 98 (4), pp. 416-418. Date of Electronic Publication: 2021 May 03.
Autor:
Decroos A; Paris-Est Créteil University (UPEC), Institut Mondor de Recherche Biomédicale (IMRB), INSERM U955, F-94010, Créteil., Cheminant M; Université de Paris, Institut Imagine, Laboratory of Hematological Disorders, INSERM UMR1163, F-75015, Paris, France; Necker-Enfants Malades University Medical Center, AP-HP Clinical Hematology, F-75015, Paris., Bruneau J; Université de Paris, Institut Imagine, Laboratory of Hematological Disorders, INSERM UMR1163, F-75015, Paris, France; Necker-Enfants Malades University Medical Center, AP-HP, Department of Pathology, F-75015, Paris., Carras S; Institute for Advanced Biosciences, 'Translational Epigenetics' team, UMR 1209/CNRS 5309, La Tronche., Parinet V; Paris-Est Créteil University (UPEC), Institut Mondor de Recherche Biomédicale (IMRB), INSERM U955, F-94010, Créteil., Pelletier L; Paris-Est Créteil University (UPEC), Institut Mondor de Recherche Biomédicale (IMRB), INSERM U955, F-94010, Créteil., Lacroix L; Paris-Est Créteil University (UPEC), Institut Mondor de Recherche Biomédicale (IMRB), INSERM U955, F-94010, Créteil, France; Université de Paris, Institut Imagine, Laboratory of Hematological Disorders, INSERM UMR1163, F-75015, Paris., Martin N; Paris-Est Créteil University (UPEC), Institut Mondor de Recherche Biomédicale (IMRB), INSERM U955, F-94010, Créteil., Giustiniani J; Paris-Est Créteil University (UPEC), Institut Mondor de Recherche Biomédicale (IMRB), INSERM U955, F-94010, Créteil., Lhermitte L; Université de Paris, Institut Necker-Enfants Malades, Laboratory of Onco-Hematology, APHP, INSERM UMR 1151, Paris., Asnafi V; Université de Paris, Institut Necker-Enfants Malades, Laboratory of Onco-Hematology, APHP, INSERM UMR 1151, Paris., Battistella M; Université Paris Cité ; INSERM U976 ; AP-HP, Department of Pathology, Saint-Louis hospital, F-75010 Paris., Lemonnier F; Paris-Est Créteil University (UPEC), Institut Mondor de Recherche Biomédicale (IMRB), INSERM U955, F-94010, Créteil, France; Henri Mondor hospital, Clinical Hematology, Unité Hémopathies Lymphoïdes, AP-HP, F-94010, Créteil., De Leval L; Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University., Sicard H; Innate Pharma, Marseille, F-13009., Bonnafous C; Innate Pharma, Marseille, F-13009., Gauthier L; Innate Pharma, Marseille, F-13009., Genestier L; Claude Bernard Lyon 1 University, ENS de Lyon, CNRS, UMR5308, INSERM U1111, CIRI, Centre International de Recherche en Infectiologie, Lymphoma Immunobiology Team (LIB), Equipe Labellisée Ligue Contre le Cancer, F-69007, Lyon, France; Hospices Civils de Lyon, Lyon., Caruso S; Henri Mondor hospital, AP-HP, Department of Pathology, F-94010, Créteil., Gaulard P; Paris-Est Créteil University (UPEC), Institut Mondor de Recherche Biomédicale (IMRB), INSERM U955, F-94010, Créteil, France; Henri Mondor hospital, AP-HP, Department of Pathology, F-94010, Créteil., Hermine O; Université de Paris, Institut Imagine, Laboratory of Hematological Disorders, INSERM UMR1163, F-75015, Paris, France; Necker-Enfants Malades University Medical Center, AP-HP Clinical Hematology, F-75015, Paris., Ortonne N; Paris-Est Créteil University (UPEC), Institut Mondor de Recherche Biomédicale (IMRB), INSERM U955, F-94010, Créteil, France; Henri Mondor hospital, AP-HP, Department of Pathology, F-94010, Créteil. nicolas.ortonne@aphp.fr.
Publikováno v:
Haematologica [Haematologica] 2023 Oct 01; Vol. 108 (10), pp. 2830-2836. Date of Electronic Publication: 2023 Oct 01.
Autor:
Chen C; HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.; Key Laboratory of Blood Safety Research of Zhejiang Province, Hangzhou, China., Wang J; HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.; Key Laboratory of Blood Safety Research of Zhejiang Province, Hangzhou, China., Xu A; Department of Blood Donation Service, Blood Center of Zhejiang Province, Hangzhou, China., He J; HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.; Key Laboratory of Blood Safety Research of Zhejiang Province, Hangzhou, China., Zhu F; HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.; Key Laboratory of Blood Safety Research of Zhejiang Province, Hangzhou, China.
Publikováno v:
HLA [HLA] 2020 Jul; Vol. 96 (1), pp. 137-138. Date of Electronic Publication: 2020 Mar 11.
Autor:
Chen C; HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.; Key Laboratory of Blood Safety Research of Zhejiang Province, Hangzhou, China., Wang J; HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.; Key Laboratory of Blood Safety Research of Zhejiang Province, Hangzhou, China., Xu G; HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.; Key Laboratory of Blood Safety Research of Zhejiang Province, Hangzhou, China., He J; HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.; Key Laboratory of Blood Safety Research of Zhejiang Province, Hangzhou, China., Zhu F; HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.; Key Laboratory of Blood Safety Research of Zhejiang Province, Hangzhou, China.
Publikováno v:
HLA [HLA] 2020 Jun; Vol. 95 (6), pp. 594-596. Date of Electronic Publication: 2020 Feb 11.
Autor:
Larid G; Rheumatology Department, Aix Marseille Univ, APHM, CHU Sainte-Marguerite, Marseille, France.; Rheumatology Department, CHU Poitiers, Poitiers, France.; LITEC Laboratory, UR 15560, University of Poitiers, Poitiers, France., Trijau S; Rheumatology Department, Aix Marseille Univ, APHM, CHU Sainte-Marguerite, Marseille, France., Barral C; Rheumatology Department, Aix Marseille Univ, APHM, CHU Sainte-Marguerite, Marseille, France., Lafforgue P; Rheumatology Department, Aix Marseille Univ, APHM, CHU Sainte-Marguerite, Marseille, France., Pham T; Rheumatology Department, Aix Marseille Univ, APHM, CHU Sainte-Marguerite, Marseille, France.
Publikováno v:
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2023 Apr 03; Vol. 62 (4), pp. e114-e116.
Autor:
Yu HC; Department of Medical Research, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi 62247, Taiwan., Huang KY; Division of Allergy, Immunology and Rheumatology, Department of Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi 62247, Taiwan.; School of Medicine, Tzu Chi University, Hualien 970, Taiwan., Lu MC; Department of Medical Research, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi 62247, Taiwan.; Division of Allergy, Immunology and Rheumatology, Department of Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi 62247, Taiwan.; School of Medicine, Tzu Chi University, Hualien 970, Taiwan., Huang Tseng HY; Division of Allergy, Immunology and Rheumatology, Department of Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi 62247, Taiwan., Liu SQ; Division of Allergy, Immunology and Rheumatology, Department of Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi 62247, Taiwan., Lai NS; Division of Allergy, Immunology and Rheumatology, Department of Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi 62247, Taiwan.; School of Medicine, Tzu Chi University, Hualien 970, Taiwan., Huang HB; Department of Biomedical Sciences, National Chung Cheng University, Chiayi 621, Taiwan.
Publikováno v:
Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2022 Oct 07; Vol. 58 (10). Date of Electronic Publication: 2022 Oct 07.
Autor:
Cheminant M; Clinical Hematology, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; Laboratory of Hematological Disorders, Institut Imagine, Université de Paris Cité, INSERM Unité Mixte de Recherche (UMR)1163, Paris, France., Lhermitte L; Laboratory of Onco-Haematology, Assistance Publique-Hôpitaux de Paris (AP-HP), INSERM UMR1151, and., Bruneau J; Laboratory of Hematological Disorders, Institut Imagine, Université de Paris Cité, INSERM Unité Mixte de Recherche (UMR)1163, Paris, France.; Department of Pathology, Assistance Publique-Hôpitaux de Paris (AP-HP), Necker-Enfants Malades University Hospital, Paris, France., Sicard H; Innate Pharma, Marseille, France., Bonnafous C; Innate Pharma, Marseille, France., Touzart A; Laboratory of Onco-Haematology, Assistance Publique-Hôpitaux de Paris (AP-HP), INSERM UMR1151, and., Bourbon E; Clinical Hematology, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; Laboratory of Hematological Disorders, Institut Imagine, Université de Paris Cité, INSERM Unité Mixte de Recherche (UMR)1163, Paris, France., Ortonne N; Department of Pathology, Groupe Hospitalier Henri Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), Créteil, France.; INSERM U955, Université Paris-Est, Créteil, France., Genestier L; CIRI, Centre International de Recherche en Infectiologie, Team Lymphoma ImmunoBiology, University of Lyon, INSERM, U1111, Université Claude Bernard Lyon 1, Centre National de la Recherche Scientifique (CNRS), UMR5308, ENS de Lyon, Hospices Civils de Lyon, Lyon, France., Gaulard P; Department of Pathology, Groupe Hospitalier Henri Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), Créteil, France.; INSERM U955, Université Paris-Est, Créteil, France., Palmic P; Clinical Hematology, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; Laboratory of Hematological Disorders, Institut Imagine, Université de Paris Cité, INSERM Unité Mixte de Recherche (UMR)1163, Paris, France., Suarez F; Clinical Hematology, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; Laboratory of Hematological Disorders, Institut Imagine, Université de Paris Cité, INSERM Unité Mixte de Recherche (UMR)1163, Paris, France., Frenzel L; Clinical Hematology, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; Laboratory of Hematological Disorders, Institut Imagine, Université de Paris Cité, INSERM Unité Mixte de Recherche (UMR)1163, Paris, France., Naveau L; Clinical Hematology, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France., Bazarbachi A; Department of Internal Medicine, Department of Anatomy, Cell Biology and Physiological Sciences American University of Beirut Medical Center, Beirut, Lebanon., Dussiot M; Laboratory of Hematological Disorders, Institut Imagine, Université de Paris Cité, INSERM Unité Mixte de Recherche (UMR)1163, Paris, France., Waast L; INSERM U1016, Centre National de la Recherche Scientifique (CNRS) UMR 8104, Université Paris Descartes, Sorbonne Paris Cité, Institut Cochin, Paris, France; and., Avettand-Fenoel V; INSERM U1016, Centre National de la Recherche Scientifique (CNRS) UMR 8104, Université Paris Descartes, Sorbonne Paris Cité, Institut Cochin, Paris, France; and.; Virology Department, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France., Brouzes C; Laboratory of Onco-Haematology, Assistance Publique-Hôpitaux de Paris (AP-HP), INSERM UMR1151, and., Pique C; INSERM U1016, Centre National de la Recherche Scientifique (CNRS) UMR 8104, Université Paris Descartes, Sorbonne Paris Cité, Institut Cochin, Paris, France; and., Lepelletier Y; Laboratory of Hematological Disorders, Institut Imagine, Université de Paris Cité, INSERM Unité Mixte de Recherche (UMR)1163, Paris, France., Asnafi V; Laboratory of Onco-Haematology, Assistance Publique-Hôpitaux de Paris (AP-HP), INSERM UMR1151, and., Marçais A; Clinical Hematology, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France., Hermine O; Clinical Hematology, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; Laboratory of Hematological Disorders, Institut Imagine, Université de Paris Cité, INSERM Unité Mixte de Recherche (UMR)1163, Paris, France.
Publikováno v:
Blood [Blood] 2022 Sep 29; Vol. 140 (13), pp. 1522-1532.
Autor:
Su T; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Duran GE; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Kwang AC; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Ramchurren N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Fling SP; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Kim YH; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA., Khodadoust MS; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2022 Aug 27; Vol. 11 (1), pp. 2115197. Date of Electronic Publication: 2022 Aug 27 (Print Publication: 2022).
Autor:
Roelens M; INSERM UMR 1160.; Université de Paris, Paris, France., de Masson A; INSERM UMR 976, Institut de Recherche Saint-Louis, Paris, France.; Université de Paris, Paris, France.; Dermatology Department., Andrillon A; Université de Paris, Paris, France.; INSERM UMR 1153., Ram-Wolff C; Dermatology Department., Biard L; Université de Paris, Paris, France.; INSERM UMR 1153.; Department of Biostatistics and Medical Information., Boisson M; Tumor Genomics and Pharmacology Department., Mourah S; INSERM UMR 976, Institut de Recherche Saint-Louis, Paris, France.; Université de Paris, Paris, France.; Tumor Genomics and Pharmacology Department., Battistella M; INSERM UMR 976, Institut de Recherche Saint-Louis, Paris, France.; Université de Paris, Paris, France.; Pathology Department., Toubert A; INSERM UMR 1160.; Université de Paris, Paris, France.; Immunology Laboratory., Bagot M; INSERM UMR 976, Institut de Recherche Saint-Louis, Paris, France.; Université de Paris, Paris, France.; Dermatology Department., Moins-Teisserenc H; INSERM UMR 1160.; Université de Paris, Paris, France.; Hematology Laboratory, Hôpital Saint-Louis, AP-HP, Paris, France.
Publikováno v:
The British journal of dermatology [Br J Dermatol] 2022 Jun; Vol. 186 (6), pp. 1010-1025.